May 17 (UPI) -- The Food and Drug Administration on Tuesday authorized the use of a single booster dose of the COVID-19 vaccine produced by Pfizer-BioNTech for children ages 5 through 11.
"While it has largely been the case that COVID-19 tends to be less severe in children than adults, the omicron wave has seen more kids getting sick with the disease and being hospitalized, and children may also experience longer term effects, even following initially mild disease," said FDA Commissioner Dr. Robert M. Califf.